The authors showed that late-stage Non-Hodgkin’s Lymphoma was resistant to therapy targeting phagocytosis checkpoint CD47, due to the compromised capacity of tumor-associated macrophages to phagocytose lymphoma cells.
[Blood]
7992332
{7992332:AAAAAAAA}
apa
50
1
171676
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/